12:00 AM
 | 
Dec 07, 1998
 |  BC Week In Review  |  Company News  |  Deals

Algene deal

AGN.B signed a letter of intent with an undisclosed biotechnology company for research into Alzheimer's disease. Under the terms of...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >